- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Coaching Changes
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: Mrs M is in Lane Hospital struggling with double Covid pneumonia.
Posted on 1/8/22 at 8:56 am to the808bass
Posted on 1/8/22 at 8:56 am to the808bass
That having your chances of dying greatly reduced is infinitely more important than simply testing positive? If you can’t grasp that simple concept, I can definitely understand why you think I don’t know what I’m talking about. Good luck.
This post was edited on 1/8/22 at 8:58 am
1
Posted on 1/8/22 at 9:09 am to Jake88
quote:
Power of attorney seemed like a great call
quote:
Why? He's the husband and already can make decisions if she is incapable.
As defined by whom?
Why take the chance?
I personally would not trust the hospital or the physicians within to keep me in the loop. It is sad to say, but my personal experience in West St. Tammany did not paint the local medical personnel in a positive light.
Feel free to dig through my posts to review my experiences. One dealt with an ER cardiologist, the other with a PA at my Primary Care office. Both dealt with the vaccine.
Posted on 1/8/22 at 9:25 am to Mr. Misanthrope
Many would recommend Zinc, as I do. Remember, the zinc must cross the cell membrane to do its viral intervention work, and it needs a transporter. Quercetn is over the counter and is such a transporter, as is hydroxychloroquine, Rx needed, and may not be filled.
Posted on 1/8/22 at 9:27 am to Mr. Misanthrope
Just curious, was she vaccinated?
Posted on 1/8/22 at 9:29 am to Rza32
He's no longer responding or posting at all.
Guessing by his posting history, no she likely wasn't.
I'm also assuming that his lack of posting means she isn't improving.
Sucks all around.
Guessing by his posting history, no she likely wasn't.
I'm also assuming that his lack of posting means she isn't improving.
Sucks all around.
Posted on 1/8/22 at 9:41 am to PeleofAnalytics
quote:
That having your chances of dying greatly reduced is infinitely more important than simply testing positive?
I still don’t think you understand what you’re arguing. But I don’t have time to teach all pigs to sing.
Posted on 1/8/22 at 9:55 am to Mr. Misanthrope
Sorry to hear this Misanthrope. Will offer up prayers for your wife
Posted on 1/8/22 at 10:24 am to Mr. Misanthrope
Damn. I’m sorry to hear that. It’s so hard to know what to do, and everyone is just trying to do what’s best for them and their family. There is so much conflicting information, from whether or not to take the vaccine, to treatments and what to do if you get sick. It’s so random, who gets hit hard and who doesn’t. Even the “experts” disagree. I’m saying a prayer for Mrs. M.
Posted on 1/8/22 at 11:54 am to Displaced
quote:Things are not going well.
I'm also assuming that his lack of posting means she isn't improving.
It’s nearly impossible to keep up with family and friends and medical persons and TD. Please know I appreciate all the support and prayers offered. It helps to not be totally alone.
Thank y’all.
Posted on 1/8/22 at 11:58 am to Mr. Misanthrope
Stay strong but don't be shy to accept help and support. Wishing for the best.
Posted on 1/8/22 at 1:04 pm to the808bass
Yes…I’m sure crafting an argument that ignores basic math/stats and that mortality rates are less important than breakthrough infections would take some time for you. I don’t blame you for not trying. You are just completely adorable in your beliefs, aren’t you
This post was edited on 1/8/22 at 1:14 pm
Posted on 1/8/22 at 1:11 pm to Mr. Misanthrope
Very sorry to hear this. I will keep her in my prayers.
Posted on 1/8/22 at 2:20 pm to Mr. Misanthrope
Sorry to hear , heck throw everything at it . Try the Benadryl and milk every 4 hours .
This post was edited on 1/8/22 at 2:22 pm
Posted on 1/8/22 at 2:23 pm to Mr. Misanthrope
If possible ask them to sit her up. If she can move around that’s better than sitting in bed
Also ask for the incentive spirometer — it help post surgical patients to nkt develop pneumonia. Maybe it could help in this situation.
Also ask for the incentive spirometer — it help post surgical patients to nkt develop pneumonia. Maybe it could help in this situation.
Posted on 1/8/22 at 2:26 pm to Mr. Misanthrope
Praying for your wife, her doctors as well as the rest of your family.
God Bless
God Bless
Posted on 1/8/22 at 2:26 pm to PeleofAnalytics
quote:
breakthrough infections
breakthrough??? I think you surely meant 'infections'.
Posted on 1/8/22 at 2:27 pm to NC_Tigah
quote:
FWIW, a number of non-medical posters are parroting use of ivermectin, azithromycin, hydroxychloroquine, zinc, etc. There is no indication whatsoever that any of those are helpful treating advanced CV-19. None!
What’s your take on Yale School of Public Health epidemiologist Harvey Risch‘s observations that identified problems with those studies such as :
*randomized controlled trials with such a small number of "events" in treatment and control arms that they "could easily happen by chance"
* studying healthcare workers who are "too healthy" for treatment to matter
*and studying hospitalized patients rather than early outpatient treatment.
He also says that because of these problems with studies (which were apparently designed for the intended conclusion), it cannot accurately be said that these medications (hydroxychloroquine and ivermectin) don’t work because they were conducted in settings where it was not intended as treatment .
Among his observations are that the FDA's website prominently warns against hydroxychloroquine usage in outpatients, with a "small text" disclaimer citing study of hospitalized patients.
He further states that the reason the FDA "has no systematic data about hydroxychloroquine use in outpatients because it blocked that usage in March of 2020.”
Is he full of shite? Or are these valid observations?
Posted on 1/8/22 at 3:46 pm to Willie Stroker
Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
There is great interest in evaluating the potential of already existing medicines against COVID-19 and many clinical trials are in progress to “repurpose” drugs normally indicated for other diseases.
Three repurposed anti-inflammatory drugs have shown significant survival benefits to date: the corticosteroid dexamethason and the interleukin-6 receptor antagonist drugs tocilizumab and sarilumab.
Ivermectin is an antiparasitic drug being investigated for repurposing against coronavirus. This meta-analysis investigated ivermectin in 23 randomized clinical trials (3349 patients).
Ivermectin did not show a statistically significant effect on survival or hospitalizations. Ivermectin displayed a borderline significant effect on duration of hospitalization in comparison with standard of care. There was no significant effect of ivermectin on time to clinical recovery or binary clinical recovery.
Currently, the World Health Organization recommends the use of ivermectin only inside clinical trials. A network of large clinical trials is in progress to validate the results seen to date.
Other repurposed treatments such as hydroxychloroquine, lopinavir/ritonavir, remdesivir, and interferon-beta have shown no significant survival benefit in large randomized trials despite initial reports of efficacy, underscoring the need for caution when interpreting early clinical trial data.
Published last month -
LINK
There is great interest in evaluating the potential of already existing medicines against COVID-19 and many clinical trials are in progress to “repurpose” drugs normally indicated for other diseases.
Three repurposed anti-inflammatory drugs have shown significant survival benefits to date: the corticosteroid dexamethason and the interleukin-6 receptor antagonist drugs tocilizumab and sarilumab.
Ivermectin is an antiparasitic drug being investigated for repurposing against coronavirus. This meta-analysis investigated ivermectin in 23 randomized clinical trials (3349 patients).
Ivermectin did not show a statistically significant effect on survival or hospitalizations. Ivermectin displayed a borderline significant effect on duration of hospitalization in comparison with standard of care. There was no significant effect of ivermectin on time to clinical recovery or binary clinical recovery.
Currently, the World Health Organization recommends the use of ivermectin only inside clinical trials. A network of large clinical trials is in progress to validate the results seen to date.
Other repurposed treatments such as hydroxychloroquine, lopinavir/ritonavir, remdesivir, and interferon-beta have shown no significant survival benefit in large randomized trials despite initial reports of efficacy, underscoring the need for caution when interpreting early clinical trial data.
Published last month -
LINK
This post was edited on 1/8/22 at 3:48 pm
Posted on 1/8/22 at 4:47 pm to Eurocat
Ivermectin, when used as a prophylactic, was shown to have a positive impact (placebo or otherwise).
Plus, this:
should speak volumes. Imho, the WHO cannot be trusted at this point (at all).
As for Ivermectin being safe, what would it hurt to be used at a later stage? What if it does work?
ETA - frick ton for a blind link.
Additionally, frick that source.
Plus, this:
quote:
Currently, the World Health Organization recommends the use of ivermectin only inside clinical trials.
should speak volumes. Imho, the WHO cannot be trusted at this point (at all).
As for Ivermectin being safe, what would it hurt to be used at a later stage? What if it does work?
ETA - frick ton for a blind link.
Additionally, frick that source.
This post was edited on 1/8/22 at 4:50 pm
Posted on 1/8/22 at 5:01 pm to jimmy the leg
frick the source?
This is the source - the publisher - If you don't find this source to be established, known and credible, I don't know what to say -
Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide
Oxford University Press
Copyright © 2021 Oxford University Press Cookie Policy Privacy Policy Legal Notice Site Map Accessibility
The Editor in Chief and His Deputies -
Editorial Board
Editor-In-Chief
Paul E. Sax, MD is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), and Professor of Medicine at Harvard Medical School. He is Editor-in-Chief of Open Forum Infectious Diseases.
Deputy Editor
Jonathan Z. Li, MD is an Associate Professor of Medicine in the Division of Infectious Diseases at the Brigham and Women’s Hospital and Harvard Medical School.
Associate Deputy Editor
Andrej Spec, MD, MSCI is an Assistant Professor in the Division of Infectious Disease at Washington University in St Louis, Missouri, where he also serves as the Associate Director of the Infectious Disease Clinical Research Unt and leads both the Invasive Mycoses Clinic as well as the Washington University Mycoses Group.
This is the source - the publisher - If you don't find this source to be established, known and credible, I don't know what to say -
Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide
Oxford University Press
Copyright © 2021 Oxford University Press Cookie Policy Privacy Policy Legal Notice Site Map Accessibility
The Editor in Chief and His Deputies -
Editorial Board
Editor-In-Chief
Paul E. Sax, MD is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), and Professor of Medicine at Harvard Medical School. He is Editor-in-Chief of Open Forum Infectious Diseases.
Deputy Editor
Jonathan Z. Li, MD is an Associate Professor of Medicine in the Division of Infectious Diseases at the Brigham and Women’s Hospital and Harvard Medical School.
Associate Deputy Editor
Andrej Spec, MD, MSCI is an Assistant Professor in the Division of Infectious Disease at Washington University in St Louis, Missouri, where he also serves as the Associate Director of the Infectious Disease Clinical Research Unt and leads both the Invasive Mycoses Clinic as well as the Washington University Mycoses Group.
This post was edited on 1/8/22 at 5:10 pm
Page 9 of 18
Popular
Back to top
Follow TigerDroppings for LSU Football News